BioStem Technologies (OTCMKTS:BSEM) Shares Down 0.8% – Time to Sell?

BioStem Technologies, Inc. (OTCMKTS:BSEM)’s stock price was down 0.8% during mid-day trading on Monday . The stock traded as low as $3.72 and last traded at $3.84. Approximately 72,843 shares traded hands during mid-day trading, an increase of 47% from the average daily volume of 49,662 shares. The stock had previously closed at $3.87.

BioStem Technologies Trading Down 0.8%

The company has a market capitalization of $64.47 million, a P/E ratio of 4.52 and a beta of -0.43. The company has a 50 day moving average price of $4.25 and a 200 day moving average price of $7.10.

BioStem Technologies (OTCMKTS:BSEM) last released its quarterly earnings data on Thursday, November 13th. The company reported $0.03 EPS for the quarter, beating the consensus estimate of $0.02 by $0.01. The company had revenue of $10.47 million during the quarter, compared to analyst estimates of $55.20 million. As a group, sell-side analysts forecast that BioStem Technologies, Inc. will post 1.41 EPS for the current fiscal year.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr.